Moderna holds the cleaner structural position, with growth as the main driver and valuation adding further support. CoStar does not offset that deficit through any equally strong structural edge elsewhere. On the market side, Moderna is in better shape — its trend is intact while CoStar's trend has broken down. That puts structure and market broadly in agreement — Moderna's lead looks more confirmed than conflicted.
The comparison is based on similar long-term financial trajectories, not sector labels. Both peer scores are relative to the S&P 500 universe, making them directly comparable.
This is not just a one-metric split: both growth and valuation materially support the lead. The overall score gap is 23 points in favour of Moderna, Inc..
These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.
This is a looser trajectory match: still usable for comparison, but not especially tight.
Most of the shared profile comes through revenue stability.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
Score differences across key dimensions.
Left means cheaper relative valuation. Higher means stronger structure.
Moderna, Inc. looks stronger on relative valuation, while the broader price setup remains mixed.
Valuation position uses peer-relative PE percentile (idx_pct_pe) and peer-relative valuation score where available.
Where CSGP and MRNA each sit in their own 5-year price and valuation history.
Describes historical entry positioning only. Descriptive — not investment advice.
Growth adds another layer to the lead, with a very wide gap in revenue growth between the two companies.
CoStar Group, Inc. still shows lower market-fundamental divergence, which keeps the wider picture mixed rather than completely one-sided.
Growth is the clearest driver, and valuation also supports Moderna, Inc.'s broader structural position.
Break down the CSGP vs MRNA comparison across all dimensions with the full interactive tool.
Explore how CSGP and MRNA each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.